IP Verse

Manufacturing Methods To Control C Terminal Lysine, Galactose And Sialic Acid Content In Recombinant Proteins - EP2970980

PATENT ANALYSIS

Patent Details

Grant Date
Jul 27, 2022
Company
JANSSEN BIOLOGICS B.V.
Oppositions

CABINET LAVOIX

More patents of Janssen Biologics B.V.

EP2970980

Want to monitor this patent?

Feel free to send us a message here and we will get back to you